Medicare Enrolled
Dr. Peter Kuzmick, DO
Internal Medicine · Manasquan, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kuzmick from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuzmick?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kuzmick
Dr. Peter Kuzmick is an internal medicine specialist in Manasquan, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kuzmick performed 1,656 Medicare services across 1,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kuzmick received a total of $18,129 from 70 pharmaceutical and/or device companies across 1106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kuzmick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in NJ
$18,129 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,656
Medicare services
Top 28% in NJ for internal medicine
1,164
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~83 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
620 | $71 | $154 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
478 | $101 | $244 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
121 | $27 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
89 | $136 | $238 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
56 | $72 | $170 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
52 | $11 | $48 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
51 | $2 | $11 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
33 | $4 | $5 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
23 | $38 | $107 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
22 | $174 | $343 |
| Annual depression screening | 21 | $20 | $66 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
19 | $175 | $283 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
12 | $4 | $9 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,129
Total received (2018-2024)
Avg $2,590/year across 7 years
Top 4% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,129 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,487
2023
$2,565
2022
$3,518
2021
$2,690
2020
$2,312
2019
$2,842
2018
$1,714
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$417
Amgen Inc.
$286
Lilly USA, LLC
$265
ABBVIE INC.
$237
Novo Nordisk Inc
$232
E.R. Squibb & Sons, L.L.C.
$159
PFIZER INC.
$140
GlaxoSmithKline, LLC.
$114
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$113
Exact Sciences Corporation
$88
Bayer Healthcare Pharmaceuticals Inc.
$77
Astellas Pharma US Inc
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Abbott Laboratories
$42
Tolmar, Inc.
$33
Insulet Corporation
$24
SANOFI-AVENTIS U.S. LLC
$21
Boston Scientific Corporation
$21
Novartis Pharmaceuticals Corporation
$17
Daiichi Sankyo Inc.
$17
Almatica Pharma LLC
$17
Xeris Pharmaceuticals, Inc.
$17
Vanda Pharmaceuticals Inc.
$16
Esperion Therapeutics, Inc.
$15
Axsome Therapeutics, Inc.
$13
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,719
Novo Nordisk Inc
$2,492
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,148
Lilly USA, LLC
$1,118
GlaxoSmithKline, LLC.
$1,038
PFIZER INC.
$995
Amgen Inc.
$766
Boehringer Ingelheim Pharmaceuticals, Inc.
$724
ABBVIE INC.
$718
Bayer HealthCare Pharmaceuticals Inc.
$589
Janssen Pharmaceuticals, Inc
$447
Amarin Pharma Inc.
$395
Merck Sharp & Dohme Corporation
$362
OptiNose US, Inc.
$358
Boston Scientific Corporation
$356
Teva Pharmaceuticals USA, Inc.
$356
Bayer Healthcare Pharmaceuticals Inc.
$353
SANOFI-AVENTIS U.S. LLC
$339
Takeda Pharmaceuticals U.S.A., Inc.
$273
E.R. Squibb & Sons, L.L.C.
$268
Kowa Pharmaceuticals America, Inc.
$266
Astellas Pharma US Inc
$175
Abbott Laboratories
$174
Daiichi Sankyo Inc.
$134
Esperion Therapeutics, Inc.
$110
Exact Sciences Corporation
$105
Shire North American Group Inc
$88
Radius Health, Inc.
$79
Novartis Pharmaceuticals Corporation
$74
Tolmar, Inc.
$67
Eisai Inc.
$66
Biohaven Pharmaceutical Holding Company Ltd.
$57
Genentech USA, Inc.
$54
Allergan, Inc.
$53
TOPCON HEALTHCARE SOLUTIONS, INC.
$43
Hikma Pharmaceuticals USA
$43
Lundbeck LLC
$43
Merck Sharp & Dohme LLC
$42
Purdue Pharma L.P.
$38
Bausch Health US, LLC
$30
Otsuka America Pharmaceutical, Inc.
$30
Axsome Therapeutics, Inc.
$30
Jazz Pharmaceuticals Inc.
$29
BOSTON SCIENTIFIC CORPORATION
$28
Collegium Pharmaceutical, Inc.
$28
MannKind Corporation
$27
JAZZ PHARMACEUTICALS INC.
$26
VIVUS, Inc.
$26
Nalpropion Pharmaceuticals LLC
$25
Insulet Corporation
$24
Allergan Inc.
$23
Sunovion Pharmaceuticals Inc.
$20
Regeneron Healthcare Solutions, Inc.
$17
Almatica Pharma LLC
$17
Xeris Pharmaceuticals, Inc.
$17
Vanda Pharmaceuticals Inc.
$16
Supernus Pharmaceuticals, Inc.
$16
Endo Pharmaceuticals Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Optinose US, Inc.
$15
Antares Pharma, Inc.
$14
Aytu BioScience, Inc
$14
SANOFI PASTEUR INC.
$14
Currax Pharmaceuticals LLC
$14
Eyevance Pharmaceuticals LLC
$13
BioDelivery Sciences International, Inc.
$13
EISAI INC.
$13
OPKO Pharmaceuticals, LLC
$12
Noden Pharma USA Inc
$12
Strongbridge US INC.
$12
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADACEL · AFREZZA · AIRSUPRA · AJOVY · AMYVID · ANORO · ANORO ELLIPTA · APLENZIN · APTIOM · Aimovig · AirDuo Digihaler · Amitiza · BASAGLAR · BELSOMRA · BEXSERO · BOOSTRIX · BREO · BREZTRI · BUNAVAIL 2.1 mg 30-count box · Belviq · CAMZYOS · CHANTIX · COLOGUARD · CONTRAVE · Cologuard Collection Kit · DUPIXENT · Dayvigo · ELIQUIS · EMBEDA · EMGALITY · Edarbi · Entyvio · FANAPT · FARXIGA · FASENRA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre Pro · GARDASIL 9 · GENERAL PAIN MANAGEMENT · General - Pain Management · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · LEQVIO · LINZESS · LOREEV XR · LYRICA · Levemir · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYDAYIS · MYRBETRIQ · Mitigare · NASCOBAL · NEXLETOL · NORTHERA · NURTEC ODT · Natesto · OTREXUP · Omnipod · Otezla · Ozempic · PANCREAZE · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · ProAir Digihaler · QULIPTA · RAYALDEE · REXULTI · RYBELSUS · Repatha · Ryaltris · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYMPROIC · Saxenda · Sunosi · TEKTURNA · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TZIELD · Tobradex ST · Tresiba · Trintellix · Tymlos · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XTAMPZA · XYOSTED · Xhance · Xofluza · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
705
Per 100K population
109.5
County median income
$122,727
Nearest hospital
OCEAN MEDICAL CENTER
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kuzmick is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NJ), with low-engagement industry engagement in the top 4% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kuzmick experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kuzmick performed 620 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kuzmick receive payments from pharmaceutical companies?
Yes. Dr. Kuzmick received a total of $18,129 from 70 companies across 1,106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuzmick's costs compare to other internal medicine physicians in Manasquan?
Dr. Kuzmick's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuzmick) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Manasquan
Browse internal medicine physicians in Manasquan ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology